Antimicrobial Peptides: a New Frontier in Antifungal Therapy
暂无分享,去创建一个
[1] Ding Xu,et al. Zinc Binding by Histatin 5 Promotes Fungicidal Membrane Disruption in C. albicans and C. glabrata , 2020, Journal of fungi.
[2] E. Longhi,et al. Co-administration of H-ferritin-doxorubicin and Trastuzumab in neoadjuvant setting improves efficacy and prevents cardiotoxicity in HER2 + murine breast cancer model , 2020, Scientific Reports.
[3] I. Silva-Pereira,et al. Mechanisms of action of antimicrobial peptides ToAP2 and NDBP-5.7 against Candida albicans planktonic and biofilm cells , 2020, Scientific Reports.
[4] Paul D. Cotter,et al. Antifungal Peptides as Therapeutic Agents , 2020, Frontiers in Cellular and Infection Microbiology.
[5] Zhiliang Yu,et al. Mechanisms of bactericidal action and resistance of polymyxins for Gram-positive bacteria , 2020, Applied Microbiology and Biotechnology.
[6] D. Becher,et al. Proteomic Adaptation of Streptococcus pneumoniae to the Human Antimicrobial Peptide LL-37 , 2020, Microorganisms.
[7] P. Johnston,et al. Resistance Evolution Against Antimicrobial Peptides in Staphylococcus aureus Alters Pharmacodynamics Beyond the MIC , 2020, Frontiers in Microbiology.
[8] L. Larson,et al. Hope on the Horizon: Novel Fungal Treatments in Development , 2020, Open forum infectious diseases.
[9] Tuo-Hung Hou,et al. SLIM: Simultaneous Logic-in-Memory Computing Exploiting Bilayer Analog OxRAM Devices , 2018, Scientific Reports.
[10] G. Chinea,et al. Design of a Helical-Stabilized, Cyclic, and Nontoxic Analogue of the Peptide Cm-p5 with Improved Antifungal Activity , 2019, ACS omega.
[11] Zhaoxin Lu,et al. C16-Fengycin A affect the growth of Candida albicans by destroying its cell wall and accumulating reactive oxygen species , 2019, Applied Microbiology and Biotechnology.
[12] L. Majoros,et al. Synergistic effect of nikkomycin Z with caspofungin and micafungin against Candida albicans and Candida parapsilosis biofilms , 2019, Letters in applied microbiology.
[13] M. F. Fernandes-Pedrosa,et al. Biodegradable cross-linked chitosan nanoparticles improve anti-Candida and anti-biofilm activity of TistH, a peptide identified in the venom gland of the Tityus stigmurus scorpion. , 2019, Materials science & engineering. C, Materials for biological applications.
[14] H. Osada. Discovery and applications of nucleoside antibiotics beyond polyoxin , 2019, The Journal of Antibiotics.
[15] Larry R. Smith,et al. First-in-Human Phase 1 Study To Assess Safety, Tolerability, and Pharmacokinetics of a Novel Antifungal Drug, VL-2397, in Healthy Adults , 2019, Antimicrobial Agents and Chemotherapy.
[16] Larry R. Smith,et al. The Siderophore Transporter Sit1 Determines Susceptibility to the Antifungal VL-2397 , 2019, Antimicrobial Agents and Chemotherapy.
[17] Kiyomitsu Katsumata,et al. ASP2397 Is a Novel Natural Compound That Exhibits Rapid and Potent Fungicidal Activity against Aspergillus Species through a Specific Transporter , 2019, Antimicrobial Agents and Chemotherapy.
[18] P. Permi,et al. Characterization of the interaction of the antifungal and cytotoxic cyclic glycolipopeptide hassallidin with sterol-containing lipid membranes. , 2019, Biochimica et biophysica acta. Biomembranes.
[19] M. Aida,et al. Molecular Basis of Mannose Recognition by Pradimicins and their Application to Microbial Cell Surface Imaging. , 2019, Cell chemical biology.
[20] M. Lorenz,et al. Antifungal Activity of the Enterococcus faecalis Peptide EntV Requires Protease Cleavage and Disulfide Bond Formation , 2019, mBio.
[21] C. L. Telzrow,et al. Roles for Stress Response and Cell Wall Biosynthesis Pathways in Caspofungin Tolerance in Cryptococcus neoformans , 2019, Genetics.
[22] H. Rahimi,et al. Antifungal effects of indolicidin-conjugated gold nanoparticles against fluconazole-resistant strains of Candida albicans isolated from patients with burn infection , 2019, International journal of nanomedicine.
[23] C. Bernard,et al. Natural Products from Cyanobacteria: Focus on Beneficial Activities , 2019, Marine drugs.
[24] Muhammad Arif,et al. Plant defensins: types, mechanism of action and prospects of genetic engineering for enhanced disease resistance in plants , 2019, 3 Biotech.
[25] Junling Shi,et al. Capability of iturin from Bacillus subtilis to inhibit Candida albicans in vitro and in vivo , 2019, Applied Microbiology and Biotechnology.
[26] N. Matsumori,et al. The Perpendicular Orientation of Amphotericin B Methyl Ester in Hydrated Lipid Bilayers Supports the Barrel-Stave Model. , 2019, Biochemistry.
[27] Ronald N. Jones,et al. Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997–2016 , 2019, Open forum infectious diseases.
[28] Balasubramanian Velramar,et al. Investigation of antifungal activity of surfactin against mycotoxigenic phytopathogenic fungus Fusarium moniliforme and its impact in seed germination and mycotoxicosis. , 2019, Pesticide biochemistry and physiology.
[29] C. Quan,et al. Fungi-derived lipopeptide antibiotics developed since 2000 , 2019, Peptides.
[30] W. Melchers,et al. Voriconazole Resistance and Mortality in Invasive Aspergillosis: A Multicenter Retrospective Cohort Study. , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[31] P. Contursi,et al. Antifungal and anti-biofilm activity of the first cryptic antimicrobial peptide from an archaeal protein against Candida spp. clinical isolates , 2018, Scientific Reports.
[32] S. Ōmura,et al. Pestiocandin, a new papulacandin class antibiotic isolated from Pestalotiopsis humus , 2018, The Journal of Antibiotics.
[33] T. Lu,et al. Identification of Novel Cryptic Multifunctional Antimicrobial Peptides from the Human Stomach Enabled by a Computational-Experimental Platform. , 2018, ACS synthetic biology.
[34] M. Khoobi,et al. Synthesis, characterization and antifungal activity of a novel formulated nanocomposite containing Indolicidin and Graphene oxide against disseminated candidiasis. , 2018, Journal de mycologie medicale.
[35] Qian Yang,et al. Surfactin Inhibits Membrane Fusion during Invasion of Epithelial Cells by Enveloped Viruses , 2018, Journal of Virology.
[36] M. Rouabhia,et al. Dermaseptin‐S1 decreases Candida albicans growth, biofilm formation and the expression of hyphal wall protein 1 and aspartic protease genes , 2018, Journal of applied microbiology.
[37] Irina S Druzhinina,et al. Hyporientalin A, an anti-Candida peptaibol from a marine Trichoderma orientale , 2018, World Journal of Microbiology and Biotechnology.
[38] M. Fisher,et al. Worldwide emergence of resistance to antifungal drugs challenges human health and food security , 2018, Science.
[39] J. Schröder,et al. Psoriasin, a novel anti-Candida albicans adhesin , 2018, Journal of Molecular Medicine.
[40] Jinghua Li,et al. Actinobacteria–Derived peptide antibiotics since 2000 , 2018, Peptides.
[41] T. Lu,et al. In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design , 2018, Nature Communications.
[42] M. Selsted,et al. Fungicidal Potency and Mechanisms of θ-Defensins against Multidrug-Resistant Candida Species , 2018, Antimicrobial Agents and Chemotherapy.
[43] Guozhi Yu,et al. Predicting drug resistance evolution: insights from antimicrobial peptides and antibiotics , 2017, bioRxiv.
[44] Kwan-Kyu Park,et al. Antifungal Effects of Bee Venom Components on Trichophyton rubrum: A Novel Approach of Bee Venom Study for Possible Emerging Antifungal Agent , 2018, Annals of dermatology.
[45] M. Tani,et al. Overexpression of PDR16 confers resistance to complex sphingolipid biosynthesis inhibitor aureobasidin A in yeast Saccharomyces cerevisiae , 2018, FEMS microbiology letters.
[46] B. Rathod,et al. Novel actinomycin group compound from newly isolated Streptomyces sp. RAB12: isolation, characterization, and evaluation of antimicrobial potential , 2018, Applied Microbiology and Biotechnology.
[47] Joseph Heitman,et al. The Fungal Kingdom , 2017 .
[48] T. Lazaridis,et al. Transmembrane Pore Structures of β-Hairpin Antimicrobial Peptides by All-Atom Simulations. , 2017, The journal of physical chemistry. B.
[49] J. Latgé,et al. The Fungal Cell Wall: Structure, Biosynthesis, and Function , 2017, Microbiology spectrum.
[50] M. Pinedo,et al. Antimicrobial activity and mechanism of action of a thionin‐like peptide from Capsicum annuum fruits and combinatorial treatment with fluconazole against Fusarium solani , 2017, Biopolymers.
[51] M. Lorenz,et al. Enterococcus faecalis bacteriocin EntV inhibits hyphal morphogenesis, biofilm formation, and virulence of Candida albicans , 2017, Proceedings of the National Academy of Sciences.
[52] K. Roelants,et al. An orthologue of the host‐defense protein psoriasin (S100A7) is expressed in frog skin , 2017, Developmental and comparative immunology.
[53] I. Kyriakidis,et al. Clinical hepatotoxicity associated with antifungal agents , 2016, Expert opinion on drug safety.
[54] B. Cammue,et al. Antimicrobial Peptides as a Strategy to Combat Fungal Biofilms. , 2016, Current topics in medicinal chemistry.
[55] A. Fujie,et al. ASP2397: a novel antifungal agent produced by Acremonium persicinum MF-347833 , 2016, The Journal of Antibiotics.
[56] Yoonkyung Park,et al. The therapeutic applications of antimicrobial peptides (AMPs): a patent review , 2017, Journal of Microbiology.
[57] O. Franco,et al. Activity of Scorpion Venom-Derived Antifungal Peptides against Planktonic Cells of Candida spp. and Cryptococcus neoformans and Candida albicans Biofilms , 2016, Front. Microbiol..
[58] V. Balcão,et al. Alternatives to overcoming bacterial resistances: State-of-the-art. , 2016, Microbiological research.
[59] M. F. Fernandes-Pedrosa,et al. Characterization of TistH, a multifunctional peptide from the scorpion Tityus stigmurus: Structure, cytotoxicity and antimicrobial activity. , 2016, Toxicon : official journal of the International Society on Toxinology.
[60] D. G. Lee,et al. Cecropin A‐induced apoptosis is regulated by ion balance and glutathione antioxidant system in Candida albicans , 2016, IUBMB life.
[61] N. Caroff,et al. Identification and Biological Activities of Long‐Chain Peptaibols Produced by a Marine‐Derived Strain of Trichoderma longibrachiatum , 2016, Chemistry & biodiversity.
[62] Lingaraja Jena,et al. Computational Approach in Understanding Mechanism of Action of Isoniazidand Drug Resistance , 2016 .
[63] T. Chiller,et al. The Global Burden of Fungal Diseases. , 2016, Infectious disease clinics of North America.
[64] J. Frisvad,et al. Aspergillus mulundensis sp. nov., a new species for the fungus producing the antifungal echinocandin lipopeptides, mulundocandins , 2015, The Journal of Antibiotics.
[65] M. da Cunha,et al. Thionin-like peptide from Capsicum annuum fruits: mechanism of action and synergism with fluconazole against Candida species , 2016, BMC Microbiology.
[66] Roland R. Regoes,et al. Combination Effects of Antimicrobial Peptides , 2016, Antimicrobial Agents and Chemotherapy.
[67] D. Stevens,et al. Mycologic Endocrinology. , 2016, Advances in experimental medicine and biology.
[68] J. Grötzinger,et al. Disulphide-reduced psoriasin is a human apoptosis-inducing broad-spectrum fungicide , 2015, Proceedings of the National Academy of Sciences.
[69] C. León-Ramírez,et al. In vitro effect of recombinant amaranth cystatin (AhCPI) on spore germination, mycelial growth, stress response and cellular integrity of Aspergillus niger and Aspergillus parasiticus , 2015, Mycology.
[70] Stefania Galdiero,et al. The identification of a novel Sulfolobus islandicus CAMP-like peptide points to archaeal microorganisms as cell factories for the production of antimicrobial molecules , 2015, Microbial Cell Factories.
[71] N. Gow,et al. Caspofungin Treatment of Aspergillus fumigatus Results in ChsG-Dependent Upregulation of Chitin Synthesis and the Formation of Chitin-Rich Microcolonies , 2015, Antimicrobial Agents and Chemotherapy.
[72] Xiaowei Zhan,et al. Activation of HIF-1α and LL-37 by commensal bacteria inhibits Candida albicans colonization , 2015, Nature Medicine.
[73] M. Starnbach,et al. Cm‐p5: an antifungal hydrophilic peptide derived from the coastal mollusk Cenchritis muricatus (Gastropoda: Littorinidae) , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[74] Mingwen Zhao,et al. The bacterial lipopeptide iturins induce Verticillium dahliae cell death by affecting fungal signalling pathways and mediate plant defence responses involved in pathogen-associated molecular pattern-triggered immunity. , 2015, Environmental microbiology.
[75] Lingaraja Jena,et al. Computational approach to understanding the mechanism of action of isoniazid, an anti-TB drug. , 2014, International journal of mycobacteriology.
[76] G. Bills,et al. New insights into the echinocandins and other fungal non-ribosomal peptides and peptaibiotics. , 2014, Natural product reports.
[77] J. Argüelles,et al. The Production of Reactive Oxygen Species Is a Universal Action Mechanism of Amphotericin B against Pathogenic Yeasts and Contributes to the Fungicidal Effect of This Drug , 2014, Antimicrobial Agents and Chemotherapy.
[78] J. Ernst,et al. Interplay between Candida albicans and the Antimicrobial Peptide Armory , 2014, Eukaryotic Cell.
[79] M. Edgerton,et al. How Does It Kill?: Understanding the Candidacidal Mechanism of Salivary Histatin 5 , 2014, Eukaryotic Cell.
[80] Juneyoung Lee,et al. Melittin triggers apoptosis in Candida albicans through the reactive oxygen species-mediated mitochondria/caspase-dependent pathway. , 2014, FEMS microbiology letters.
[81] P. Permi,et al. Hassallidins, antifungal glycolipopeptides, are widespread among cyanobacteria and are the end-product of a nonribosomal pathway , 2014, Proceedings of the National Academy of Sciences.
[82] Andrew J. Nieuwkoop,et al. Amphotericin forms an extramembranous and fungicidal sterol sponge , 2014, Nature chemical biology.
[83] Anil Kumar Singh,et al. Lipopeptides from Bacillus strain AR2 inhibits biofilm formation by Candida albicans , 2014, Antonie van Leeuwenhoek.
[84] N. Gow,et al. Modulation of Alternaria infectoria Cell Wall Chitin and Glucan Synthesis by Cell Wall Synthase Inhibitors , 2014, Antimicrobial Agents and Chemotherapy.
[85] M. Motyl,et al. Enfumafungin Derivative MK-3118 Shows Increased In Vitro Potency against Clinical Echinocandin-Resistant Candida Species and Aspergillus Species Isolates , 2013, Antimicrobial Agents and Chemotherapy.
[86] N. Gow,et al. Mannosylation in Candida albicans: role in cell wall function and immune recognition , 2013, Molecular microbiology.
[87] M. Ueda,et al. Characterization of Antimicrobial Peptides toward the Development of Novel Antibiotics , 2013, Pharmaceuticals.
[88] Z. Chi,et al. Antifungal activity of the lipopeptides produced by Bacillus amyloliquefaciens anti-CA against Candida albicans isolated from clinic , 2013, Applied Microbiology and Biotechnology.
[89] Marilyn A. Anderson,et al. Identification and Mechanism of Action of the Plant Defensin NaD1 as a New Member of the Antifungal Drug Arsenal against Candida albicans , 2013, Antimicrobial Agents and Chemotherapy.
[90] E. Novellino,et al. Novel α-MSH Peptide Analogues with Broad Spectrum Antimicrobial Activity , 2013, PloS one.
[91] Ronald N. Jones,et al. Activity of MK-3118, a new oral glucan synthase inhibitor, tested against Candida spp. by two international methods (CLSI and EUCAST). , 2013, The Journal of antimicrobial chemotherapy.
[92] S. Tay,et al. The inhibitory effects of aureobasidin A on Candida planktonic and biofilm cells , 2013, Mycoses.
[93] F. Tangy,et al. In vitro antiviral activity of dermaseptin S4 and derivatives from amphibian skin against herpes simplex virus type 2 , 2013, Journal of medical virology.
[94] C. Stenland,et al. A practical and scalable manufacturing process for an anti-fungal agent, Nikkomycin Z. , 2013, Organic process research & development.
[95] T. Calandra,et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[96] M. Bassetti,et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[97] N. Gow,et al. Elevated Chitin Content Reduces the Susceptibility of Candida Species to Caspofungin , 2012, Antimicrobial Agents and Chemotherapy.
[98] P. Fritz,et al. Inhibition of dermatophytes by the antimicrobial peptides human β-defensin-2, ribonuclease 7 and psoriasin. , 2012, Medical mycology.
[99] Lixin Zhang,et al. Optimization for the Production of Surfactin with a New Synergistic Antifungal Activity , 2012, PloS one.
[100] O. Franco,et al. Functional characterization of a synthetic hydrophilic antifungal peptide derived from the marine snail Cenchritis muricatus. , 2012, Biochimie.
[101] Daniel S. Palacios,et al. Amphotericin primarily kills yeast by simply binding ergosterol , 2012, Proceedings of the National Academy of Sciences.
[102] Guangshun Wang. Post-translational Modifications of Natural Antimicrobial Peptides and Strategies for Peptide Engineering. , 2011, Current biotechnology.
[103] N. Gow,et al. Elevated Cell Wall Chitin in Candida albicans Confers Echinocandin Resistance In Vivo , 2011, Antimicrobial Agents and Chemotherapy.
[104] D. Bierer,et al. New β-glucan inhibitors as antifungal drugs , 2011, Expert opinion on therapeutic patents.
[105] H. Vogel,et al. The expanding scope of antimicrobial peptide structures and their modes of action. , 2011, Trends in biotechnology.
[106] Robert E. W. Hancock,et al. Multifunctional cationic host defence peptides and their clinical applications , 2011, Cellular and Molecular Life Sciences.
[107] C. Lan,et al. Human Antimicrobial Peptide LL-37 Inhibits Adhesion of Candida albicans by Interacting with Yeast Cell-Wall Carbohydrates , 2011, PloS one.
[108] Zhaoxin Lu,et al. Antifungal activity and mechanism of fengycin in the presence and absence of commercial surfactin against Rhizopus stolonifer , 2011, The Journal of Microbiology.
[109] M. Busman,et al. Fusarium verticillioides chitin synthases CHS5 and CHS7 are required for normal growth and pathogenicity , 2011, Current Genetics.
[110] C. Santa-Catarina,et al. Antifungal Activity of PvD1 Defensin Involves Plasma Membrane Permeabilization, Inhibition of Medium Acidification, and Induction of ROS in Fungi Cells , 2011, Current Microbiology.
[111] Ivone M. Martins,et al. Differential Activities of Three Families of Specific β(1,3)Glucan Synthase Inhibitors in Wild-type and Resistant Strains of Fission Yeast* , 2010, The Journal of Biological Chemistry.
[112] Giulio Superti-Furga,et al. A Computational Approach to Analyze the Mechanism of Action of the Kinase Inhibitor Bafetinib , 2010, PLoS Comput. Biol..
[113] N. Gow,et al. Chitin synthesis and fungal pathogenesis , 2010, Current opinion in microbiology.
[114] M. Edgerton,et al. Salivary histatin 5 internalization by translocation, but not endocytosis, is required for fungicidal activity in Candida albicans , 2010, Molecular microbiology.
[115] D. G. Lee,et al. Melittin induces apoptotic features in Candida albicans. , 2010, Biochemical and biophysical research communications.
[116] Georg E. Fantner,et al. Kinetics of Antimicrobial Peptide Activity Measured on Individual Bacterial Cells Using High Speed AFM , 2010, Nature nanotechnology.
[117] M. Kawada,et al. Leucinostatin A inhibits prostate cancer growth through reduction of insulin‐like growth factor‐I expression in prostate stromal cells , 2009, International journal of cancer.
[118] M. Kołaczkowski,et al. The antifungal properties of chicken egg cystatin against Candida yeast isolates showing different levels of azole resistance , 2009, Mycoses.
[119] Helgi I. Ingólfsson,et al. Lipid bilayer regulation of membrane protein function: gramicidin channels as molecular force probes , 2010, Journal of The Royal Society Interface.
[120] Ju Hyun Cho,et al. Buforins: histone H2A-derived antimicrobial peptides from toad stomach. , 2009, Biochimica et biophysica acta.
[121] S. Ōmura,et al. In vitro and in vivo antitrypanosomal activities of three peptide antibiotics: leucinostatin A and B, alamethicin I and tsushimycin , 2009, The Journal of Antibiotics.
[122] M. Leippe,et al. Antimicrobial activity of bovine psoriasin. , 2009, Veterinary microbiology.
[123] J. Galgiani,et al. Pharmacokinetics of Nikkomycin Z after Single Rising Oral Doses , 2009, Antimicrobial Agents and Chemotherapy.
[124] B. Kofler,et al. Anti‐Candida activity of α‐melanocyte‐stimulating hormone (α‐MSH) peptides , 2009, Journal of leukocyte biology.
[125] P. Aeed,et al. Inhibition of Inositol Phosphorylceramide Synthase by the Cyclic Peptide Aureobasidin A , 2009, Antimicrobial Agents and Chemotherapy.
[126] Seong-Cheol Park,et al. Pr-1, a novel antifungal protein from pumpkin rinds , 2009, Biotechnology Letters.
[127] M. Cunha,et al. Isolation, characterization and cloning of a cDNA encoding a new antifungal defensin from Phaseolus vulgaris L. seeds , 2008, Peptides.
[128] R. Nagaraj,et al. Antifungal Activities of Human Beta-Defensins HBD-1 to HBD-3 and Their C-Terminal Analogs Phd1 to Phd3 , 2008, Antimicrobial Agents and Chemotherapy.
[129] D. Elmore,et al. Investigating the nucleic acid interactions and antimicrobial mechanism of buforin II , 2008, FEBS letters.
[130] Seong-Cheol Park,et al. Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions. , 2008, Biochimica et biophysica acta.
[131] Alistair J. P. Brown,et al. Immune Recognition of Candida albicans β-glucan by Dectin-1 , 2007 .
[132] S. Vylkova,et al. Histatin 5 Initiates Osmotic Stress Response in Candida albicans via Activation of the Hog1 Mitogen-Activated Protein Kinase Pathway , 2007, Eukaryotic Cell.
[133] D. Perlin. Resistance to echinocandin-class antifungal drugs. , 2007, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[134] Xilin Zhao,et al. Mutant selection window hypothesis updated. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[135] E. Graziani,et al. Septocylindrins A and B: peptaibols produced by the terrestrial fungus Septocylindrium sp. LL-Z1518. , 2007, Journal of natural products.
[136] Trees Jansen,et al. Immune recognition of Candida albicans beta-glucan by dectin-1. , 2007, The Journal of infectious diseases.
[137] H. Vogel,et al. Structure-function analysis of tritrpticin analogs: potential relationships between antimicrobial activities, model membrane interactions, and their micelle-bound NMR structures. , 2006, Biophysical journal.
[138] M. Benincasa,et al. Fungicidal activity of five cathelicidin peptides against clinically isolated yeasts. , 2006, The Journal of antimicrobial chemotherapy.
[139] Y. Pommier,et al. Covalent binding of the natural antimicrobial peptide indolicidin to DNA abasic sites , 2006, Nucleic acids research.
[140] E. Zmuda,et al. Antimicrobial Activities and Structures of Two Linear Cationic Peptide Families with Various Amphipathic β-Sheet and α-Helical Potentials , 2005, Antimicrobial Agents and Chemotherapy.
[141] C. Vágvölgyi,et al. Peptaibols and related peptaibiotics of Trichoderma. A review. , 2005, Acta microbiologica et immunologica Hungarica.
[142] A. Ortiz,et al. Further aspects on the hemolytic activity of the antibiotic lipopeptide iturin A. , 2005, Biochimica et biophysica acta.
[143] L. Sijtsma,et al. Antifungal activity of synthetic peptides derived from Impatiens balsamina antimicrobial peptides Ib-AMP1 and Ib-AMP4 , 2005, Peptides.
[144] Suzanne M Johnson,et al. Comparison of susceptibility of fungal isolates to lufenuron and nikkomycin Z alone or in combination with itraconazole. , 2005, American journal of veterinary research.
[145] J. van Marle,et al. Candidacidal effects of two antimicrobial peptides: histatin 5 causes small membrane defects, but LL-37 causes massive disruption of the cell membrane. , 2005, The Biochemical journal.
[146] J. Schröder,et al. Psoriatic scales: a promising source for the isolation of human skin‐derived antimicrobial proteins , 2005, Journal of leukocyte biology.
[147] K. Brogden. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? , 2005, Nature Reviews Microbiology.
[148] M. Ferguson,et al. Mnt1p and Mnt2p of Candida albicans Are Partially Redundant α-1,2-Mannosyltransferases That Participate in O-Linked Mannosylation and Are Required for Adhesion and Virulence* , 2005, Journal of Biological Chemistry.
[149] J. Ernst,et al. PMT family of Candida albicans: five protein mannosyltransferase isoforms affect growth, morphogenesis and antifungal resistance , 2004, Molecular microbiology.
[150] K. Fuji,et al. New antibiotics, trichopolyns A and B: Isolation and biological activity , 1978, Experientia.
[151] J. Schröder,et al. Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection , 2005, Nature Immunology.
[152] K. Hahm,et al. Effects of N- and C-terminal truncation of HP (2-20) from Helicobacter pylori ribosomal protein L1 (RPL1) on its anti-microbial activity , 2005, Biotechnology Letters.
[153] C. Slayman,et al. The TRK1 Potassium Transporter Is the Critical Effector for Killing of Candida albicans by the Cationic Protein, Histatin 5* , 2004, Journal of Biological Chemistry.
[154] G. Alangaden,et al. In-vitro activity of nikkomycin Z alone and in combination with polyenes, triazoles or echinocandins against Aspergillus fumigatus. , 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[155] B. Thomma,et al. Defensins from Insects and Plants Interact with Fungal Glucosylceramides* , 2004, Journal of Biological Chemistry.
[156] K. Hahm,et al. Antifungal mechanism of a cysteine-rich antimicrobial peptide, Ib-AMP1, from Impatiens balsamina against Candida albicans , 1999, Biotechnology Letters.
[157] J. Bland,et al. Inhibition of some mycotoxigenic fungi by iturin A, a peptidolipid produced by Bacillus subtilis , 1991, Mycopathologia.
[158] E. Medina-Acosta,et al. Prevention of lethal murine candidiasis using HP (2–20), an antimicrobial peptide derived from the N-terminus of Helicobacter pylori ribosomal protein L1 , 2003, Peptides.
[159] Y. Igarashi,et al. Apoptosis-like cell death of Saccharomyces cerevisiae induced by a mannose-binding antifungal antibiotic, pradimicin. , 2003, The Journal of antibiotics.
[160] M. Papagianni. Ribosomally synthesized peptides with antimicrobial properties: biosynthesis, structure, function, and applications. , 2003, Biotechnology advances.
[161] M. Edgerton,et al. Candida albicans Ssa1/2p Is the Cell Envelope Binding Protein for Human Salivary Histatin 5* , 2003, Journal of Biological Chemistry.
[162] Seong-Cheol Park,et al. Fungicidal effect of indolicidin and its interaction with phospholipid membranes. , 2003, Biochemical and Biophysical Research Communications - BBRC.
[163] A. Ramamoorthy,et al. MSI-78, an analogue of the magainin antimicrobial peptides, disrupts lipid bilayer structure via positive curvature strain. , 2003, Biophysical journal.
[164] Robert Finking,et al. Biosynthesis of nonribosomal peptides , 2003 .
[165] D. Stevens,et al. Zeamatin, clotrimazole and nikkomycin Z in therapy of a Candida vaginitis model. , 2002, The Journal of antimicrobial chemotherapy.
[166] T. Hosoya,et al. F-10748 A1, A2, B1, B2, C1, C2, D1 and D2, novel papulacandins. , 2002, The Journal of antibiotics.
[167] D. Barrett. From natural products to clinically useful antifungals. , 2002, Biochimica et biophysica acta.
[168] I. Yoo,et al. Atroviridins A-C and neoatroviridins A-D, novel peptaibol antibiotics produced by Trichoderma atroviride F80317. I. Taxonomy, fermentation, isolation and biological activities. , 2002, The Journal of antibiotics.
[169] W. Gerwick,et al. Structure and absolute stereochemistry of hectochlorin, a potent stimulator of actin assembly. , 2002, Journal of natural products.
[170] Hee-Moon Park,et al. Inhibitory effect of nikkomycin Z on chitin synthases in Candida albicans , 2002, Yeast.
[171] K. Hahm,et al. Antifungal mechanism of an antimicrobial peptide, HP (2--20), derived from N-terminus of Helicobacter pylori ribosomal protein L1 against Candida albicans. , 2002, Biochemical and biophysical research communications.
[172] T. Walsh,et al. Synergy, Pharmacodynamics, and Time-Sequenced Ultrastructural Changes of the Interaction between Nikkomycin Z and the Echinocandin FK463 against Aspergillus fumigatus , 2001, Antimicrobial Agents and Chemotherapy.
[173] F. Oppenheim,et al. The human salivary peptide histatin 5 exerts its antifungal activity through the formation of reactive oxygen species , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[174] R. Hancock,et al. Cationic peptides: effectors in innate immunity and novel antimicrobials. , 2001, The Lancet. Infectious diseases.
[175] Chris D. Clark,et al. Spectrographic imaging: A bird's-eye view of the health of coral reefs , 2001, Nature.
[176] S. Gordon,et al. Immune recognition: A new receptor for β-glucans , 2001, Nature.
[177] L. Yang,et al. Barrel-stave model or toroidal model? A case study on melittin pores. , 2001, Biophysical journal.
[178] H. Nikawa,et al. Antifungal activity of histatin-5 against non-albicans Candida species. , 2001, Oral microbiology and immunology.
[179] B. Wallace,et al. Peptaibols: models for ion channels. , 2001, Biochemical Society transactions.
[180] E. Anaissie,et al. Need for alternative trial designs and evaluation strategies for therapeutic studies of invasive mycoses. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[181] I. Algarra,et al. The use of 7-amino-actinomycin D in the analysis of Candida albicans phagocytosis and opsonization. , 2001, Journal of immunological methods.
[182] A. Espinel-Ingroff. In Vitro Fungicidal Activities of Voriconazole, Itraconazole, and Amphotericin B against Opportunistic Moniliaceous and Dematiaceous Fungi , 2001, Journal of Clinical Microbiology.
[183] C. Douglas. Fungal β(1,3)-d-glucan synthesis , 2001 .
[184] C. Douglas. Fungal beta(1,3)-D-glucan synthesis. , 2001, Medical mycology.
[185] J. Bruenn,et al. Salivary Histatin 5 and Human Neutrophil Defensin 1 Kill Candida albicans via Shared Pathways , 2000, Antimicrobial Agents and Chemotherapy.
[186] D. Ishiyama,et al. Heptaibin, a novel antifungal peptaibol antibiotic from Emericellopsis sp. BAUA8289. , 2000, The Journal of antibiotics.
[187] C. B. Park,et al. Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[188] J. Ernst,et al. Morphogenesis, Adhesive Properties, and Antifungal Resistance Depend on the Pmt6 Protein Mannosyltransferase in the Fungal Pathogen Candida albicans , 2000, Journal of bacteriology.
[189] E. Brizendine,et al. Comparison of Nikkomycin Z with Amphotericin B and Itraconazole for Treatment of Histoplasmosis in a Murine Model , 2000, Antimicrobial Agents and Chemotherapy.
[190] Wenyan Zhong,et al. Inhibition of Inositol Phosphorylceramide Synthase by Aureobasidin A in Candida and AspergillusSpecies , 2000, Antimicrobial Agents and Chemotherapy.
[191] J. M. Lipton,et al. Antimicrobial effects of α‐MSH peptides , 2000 .
[192] J. A. Radding,et al. Inositol phosphoryl transferases from human pathogenic fungi. , 2000, Biochimica et biophysica acta.
[193] S. Blondelle,et al. Combinatorial libraries: a tool to design antimicrobial and antifungal peptide analogues having lytic specificities for structure-activity relationship studies. , 2000, Biopolymers.
[194] B. Bechinger,et al. The structure, dynamics and orientation of antimicrobial peptides in membranes by multidimensional solid-state NMR spectroscopy. , 1999, Biochimica et biophysica acta.
[195] H. Vogel,et al. Diversity of antimicrobial peptides and their mechanisms of action. , 1999, Biochimica et biophysica acta.
[196] Franky R. G. Terras,et al. Permeabilization of Fungal Membranes by Plant Defensins Inhibits Fungal Growth , 1999, Applied and Environmental Microbiology.
[197] F. Barchiesi,et al. In-vitro activity of polycationic peptides against Cryptosporidium parvum, Pneumocystis carinii and yeast clinical isolates. , 1999, The Journal of antimicrobial chemotherapy.
[198] G. K. Johnson,et al. Production of β-Defensin Antimicrobial Peptides by the Oral Mucosa and Salivary Glands , 1999, Infection and Immunity.
[199] S. Hawser,et al. Mulundocandin, an echinocandin-like lipopeptide antifungal agent: biological activities in vitro. , 1999, The Journal of antibiotics.
[200] T. Walsh,et al. Antifungal Peptides: Novel Therapeutic Compounds against Emerging Pathogens , 1999, Antimicrobial Agents and Chemotherapy.
[201] C. Potvin,et al. Several Thaumatin-Like Proteins Bind to β-1,3-Glucans , 1998 .
[202] Alan J. Waring,et al. Activities of LL-37, a Cathelin-Associated Antimicrobial Peptide of Human Neutrophils , 1998, Antimicrobial Agents and Chemotherapy.
[203] C. B. Park,et al. Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. , 1998, Biochemical and biophysical research communications.
[204] C. Subbalakshmi,et al. Mechanism of antimicrobial action of indolicidin. , 1998, FEMS microbiology letters.
[205] S. Y. Lee,et al. Two hevein homologs isolated from the seed of Pharbitis nil L. exhibit potent antifungal activity. , 1998, Biochimica et biophysica acta.
[206] H. Yamaguchi,et al. Mode of antifungal action of benanomicin A in Saccharomyces cerevisiae. , 1997, The Journal of antibiotics.
[207] J. Smith,et al. Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis , 1997, Antimicrobial agents and chemotherapy.
[208] J. McAlpine,et al. Corynecandin: a novel antifungal glycolipid from Coryneum modonium. , 1997, The Journal of antibiotics.
[209] I. J. Evans,et al. A Novel Family of Small Cysteine-rich Antimicrobial Peptides from Seed of Impatiens balsamina Is Derived from a Single Precursor Protein* , 1997, The Journal of Biological Chemistry.
[210] D. Stevens,et al. Efficacy of nikkomycin Z against experimental pulmonary blastomycosis , 1997, Antimicrobial agents and chemotherapy.
[211] J. Schröder,et al. A peptide antibiotic from human skin , 1997, Nature.
[212] C. Kozak,et al. Identification of CRAMP, a Cathelin-related Antimicrobial Peptide Expressed in the Embryonic and Adult Mouse* , 1997, The Journal of Biological Chemistry.
[213] T. Cleveland,et al. Fungicidal activity of cecropin A , 1997, Antimicrobial agents and chemotherapy.
[214] E. Segal,et al. Adhesion of Candida albicans to epithelial cells ‐ effect of nikkomycin , 1997, Mycoses.
[215] J. M. Lipton,et al. The neuropeptide α-MSH has specific receptors on neutrophils and reduces chemotaxis in vitro , 1996, Peptides.
[216] E. Veerman,et al. Inhibition of the growth and cysteine proteinase activity of Porphyromonas gingivalis by human salivary cystatin S and chicken cystatin. , 1996, Biological chemistry.
[217] J. Takemoto,et al. In vitro antifungal and fungicidal activities and erythrocyte toxicities of cyclic lipodepsinonapeptides produced by Pseudomonas syringae pv. syringae , 1996, Antimicrobial agents and chemotherapy.
[218] S. Deshmukh,et al. Arthrichitin. A New Cell Wall Active Metabolite from Arthrinium phaeospermum. , 1996, The Journal of organic chemistry.
[219] C. Brownlee,et al. Fungal Membrane Responses Induced by Plant Defensins and Thionins* , 1996, The Journal of Biological Chemistry.
[220] Y. Shai,et al. Broad spectrum antibiotic activity of the skin-PYY. , 1996, FEBS letters.
[221] J. M. Lipton,et al. α‐MSH production, receptors, and influence on neopterin in a human monocyte/macrophage cell line , 1996 .
[222] E. Veerman,et al. Cystatins in health and disease. , 1996, Biological chemistry Hoppe-Seyler.
[223] J. M. Lipton,et al. The neuropeptide alpha-MSH has specific receptors on neutrophils and reduces chemotaxis in vitro. , 1996, Peptides.
[224] J. M. Lipton,et al. Evidence of autocrine modulation of macrophage nitric oxide synthase by alpha-melanocyte-stimulating hormone. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[225] M. Selsted,et al. Liposomal entrapment of the neutrophil-derived peptide indolicidin endows it with in vivo antifungal activity. , 1995, Biochimica et biophysica acta.
[226] J. McAlpine,et al. Fusacandins A and B; novel antifungal antibiotics of the papulacandin class from Fusarium sambucinum. II. Isolation and structural elucidation. , 1995, The Journal of antibiotics.
[227] M. Tester,et al. Role of biosurfactant and ion channel-forming activities of syringomycin in transmembrane ion flux: a model for the mechanism of action in the plant-pathogen interaction. , 1995, Molecular plant-microbe interactions : MPMI.
[228] H. Shimizu,et al. Successful treatment of Pneumocystis carinii Pneumonia in mice with benanomicin A (ME1451) , 1995, Antimicrobial agents and chemotherapy.
[229] B. Schlegel,et al. Helioferins; novel antifungal lipopeptides from Mycogone rosea: screening, isolation, structures and biological properties. , 1995, The Journal of antibiotics.
[230] Y. Lim,et al. Cepacidine A, a novel antifungal antibiotic produced by Pseudomonas cepacia. I. Taxonomy, production, isolation and biological activity. , 1994, The Journal of antibiotics.
[231] H. Vaudry,et al. Skin peptide tyrosine-tyrosine, a member of the pancreatic polypeptide family: isolation, structure, synthesis, and endocrine activity. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[232] F. Odds,et al. Molecular mechanisms of drug resistance in fungi. , 1994, Trends in microbiology.
[233] M. Okuhara,et al. WF11899A, B and C, novel antifungal lipopeptides. II. Biological properties. , 1994, The Journal of antibiotics.
[234] J. Johansson,et al. Secondary structure and membrane interaction of PR-39, a Pro+Arg-rich antibacterial peptide. , 1994, European journal of biochemistry.
[235] F. Peypoux,et al. Iturins, a special class of pore-forming lipopeptides: biological and physicochemical properties. , 1994, Toxicology.
[236] A. Mor,et al. Isolation and structure of novel defensive peptides from frog skin. , 1994, European journal of biochemistry.
[237] M. Debono,et al. Antibiotics that inhibit fungal cell wall development. , 1994, Annual review of microbiology.
[238] M. Ghannoum,et al. Fungicidal properties of defensin NP-1 and activity against Cryptococcus neoformans in vitro , 1993, Antimicrobial Agents and Chemotherapy.
[239] K. Takesako,et al. Biological properties of aureobasidin A, a cyclic depsipeptide antifungal antibiotic. , 1993, The Journal of antibiotics.
[240] F. Trautinger,et al. Production of Immunosuppressing Melanotropins By Human Keratinocytes a , 1993, Annals of the New York Academy of Sciences.
[241] T. Oki,et al. Studies on the mode of antifungal action of pradimicin antibiotics. I. Lectin-mimic binding of BMY-28864 to yeast mannan in the presence of calcium. , 1993, The Journal of antibiotics.
[242] Y. Shai,et al. Interaction of antimicrobial dermaseptin and its fluorescently labeled analogues with phospholipid membranes. , 1992, Biochemistry.
[243] J. L. Smith,et al. Pneumocandins from Zalerion arboricola. III. Structure elucidation. , 1992, The Journal of antibiotics.
[244] D. Schmatz,et al. In vitro antifungal activities and in vivo efficacies of 1,3-beta-D-glucan synthesis inhibitors L-671,329, L-646,991, tetrahydroechinocandin B, and L-687,781, a papulacandin , 1992, Antimicrobial Agents and Chemotherapy.
[245] Wayne L. Smith,et al. Indolicidin, a novel bactericidal tridecapeptide amide from neutrophils. , 1992, The Journal of biological chemistry.
[246] Y. Shai,et al. Interaction of fluorescently labeled pardaxin and its analogues with lipid bilayers. , 1991, The Journal of biological chemistry.
[247] W. K. Roberts,et al. A new family of plant antifungal proteins. , 1991, Molecular plant-microbe interactions : MPMI.
[248] R. Calderone,et al. Adherence and receptor relationships of Candida albicans. , 1991, Microbiological reviews.
[249] M. Okuhara,et al. FR900403, a new antifungal antibiotic produced by a Kernia sp. , 1990, The Journal of antibiotics.
[250] T. Oki,et al. New antifungal antibiotics, pradimicins D and E. Glycine analogs of pradimicins A and C. , 1990, The Journal of antibiotics.
[251] T. Oki,et al. Pradimicins A, B and C: new antifungal antibiotics. II. In vitro and in vivo biological activities. , 1990, The Journal of antibiotics.
[252] B. Zimmer,et al. Evaluation of nikkomycins X and Z in murine models of coccidioidomycosis, histoplasmosis, and blastomycosis , 1990, Antimicrobial Agents and Chemotherapy.
[253] K. Fukushima,et al. Dual inhibitory effects of the peptide antibiotics leucinostatins on oxidative phosphorylation in mitochondria. , 1990, Cell structure and function.
[254] T. F. Butler,et al. Synthesis and Evaluation of LY121019, a Member of a Series of Semisynthetic Analogues of the Antifungal Lipopeptide Echinocandin B a , 1988 .
[255] H. Kawaguchi,et al. Pradimicin, a novel class of potent antifungal antibiotics. , 1988, The Journal of antibiotics.
[256] H. Naganawa,et al. New antifungal antibiotics, benanomicins A and B from an actinomycete. , 1988, The Journal of antibiotics.
[257] T. Ganz,et al. In vitro killing of spores and hyphae of Aspergillus fumigatus and Rhizopus oryzae by rabbit neutrophil cationic peptides and bronchoalveolar macrophages. , 1986, The Journal of infectious diseases.
[258] F. Peypoux,et al. Interactions of antibiotics of the iturin group with human erythrocytes. , 1986, Biochimica et biophysica acta.
[259] T. Ganz,et al. Activity of rabbit leukocyte peptides against Candida albicans , 1985, Infection and immunity.
[260] M. Selsted,et al. In vitro effect of phagocyte cationic peptides on Coccidioides immitis. , 1985, The Journal of infectious diseases.
[261] M. Suzuki,et al. Structure of leucinostatin B, an uncoupler on mitochondria. , 1983, The Journal of antibiotics.
[262] J. Becker,et al. Polyoxin D inhibits growth of zoopathogenic fungi , 1983, Antimicrobial Agents and Chemotherapy.
[263] H. Yamaguchi,et al. In vitro studies of aculeacin A, a new antifungal antibiotic. , 1982, The Journal of antibiotics.
[264] P. Traxler,et al. Papulacandins, a new family of antibiotics with antifungal activity, I. Fermentation, isolation, chemical and biological characterization of papulacandins A, B, C, D and E. , 1977, The Journal of antibiotics.
[265] A. Yagi,et al. STUDIES ON ACULEACIN , 1977 .
[266] A. Yagi,et al. Studies on aculeacin. I. Isolation and characterization of aculeacin A. , 1977, The Journal of antibiotics.
[267] F. Rumjanek,et al. The peptide components of bee venom. , 1976, European journal of biochemistry.
[268] K. Kakiki,et al. STUDIES ON THE MODE OF ACTION OF POLYOXINS. VI , 1974 .
[269] F. Benz,et al. Stoffwechselprodukte von Mikroorganismen 143. Mitteilung. Echinocandin B, ein neuartiges Polypeptid‐Antibioticum aus Aspergillus nidulans var. echinulatus: Isolierung und Bausteine , 1974 .
[270] F. Benz. Echinocandin B. Ein neuartiges polypeptide-antibiotikum aus Aspergillus nidulans var. echinulatus : Isolierung und bausteine , 1974 .
[271] K. Kakiki,et al. Studies on the mode of action of polyoxins. VI. Effect of polyoxin B on chitin synthesis in polyoxin-sensitive and resistant strains of Alternaria kikuchiana. , 1974, The Journal of antibiotics.
[272] K. Yazawa,et al. A new antibiotic, leucinostatin, derived from Penicillium lilacinum. , 1973, The Journal of antibiotics.
[273] K. Isono,et al. Studies on polyoxins, antifungal antibiotics. 13. The structure of polyoxins. , 1969, Journal of the American Chemical Society.
[274] M. R. Holmes,et al. Cell wall composition of the mycelial and blastospore forms of Candida albicans. , 1968, Journal of general microbiology.
[275] M. Landy,et al. Bacillomycin; an antibiotic from Bacillus subtilis active against pathogenic fungi. , 1948, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[276] R. Synge,et al. The kinetics of low temperature acid hydrolysis of gramicidin and of some related dipeptides. , 1945, The Biochemical journal.
[277] R. Dubos,et al. STUDIES ON A BACTERICIDAL AGENT EXTRACTED FROM A SOIL BACILLUS , 1939, The Journal of experimental medicine.
[278] R. Dubos. STUDIES ON A BACTERICIDAL AGENT EXTRACTED FROM A SOIL BACILLUS , 1939, The Journal of experimental medicine.